Predict your next investment

HEALTHCARE | Medical Facilities & Services / Medical Laboratories & Research

See what CB Insights has to offer

Founded Year



Acquired | Acquired

About Analytical Bio-Chemistry Laboratories

ABC Laboratories provides IND-enabling, registration and post-commercialization analytical support for the development, quality control and lifecycle management of agrochemicals and pharmaceuticals. ABC's personalized, results-based approach to development strategy is backed by decades of experience delivering GLP and CGMP-compliant analytical testing services across all types of active pharmaceutical ingredients and formulations as well as agrochemicals. Through development know-how, cross-disciplinary technical expertise, and applied experience with evolving global regulatory frameworks, ABC helps efficiently manage programs for large and small molecule drugs, medical devices and drug-device combination products, crop biotech products and agricultural chemicals.

Analytical Bio-Chemistry Laboratories Headquarter Location

7200 East ABC Lane

Columbia, Missouri, 65202,

United States


Latest Analytical Bio-Chemistry Laboratories News

Celerity Partners Exits ABC Labs in Transaction with Evans Analytical Group (“EAG”)

Jan 29, 2019

Celerity Partners Exits ABC Labs in Transaction with Evans Analytical Group (“EAG”) Celerity Partners and other shareholders sold Analytical Bio-Chemistry Laboratories, Inc., of Columbia, Missouri (“ABC Labs”) to EAG. ABC is a leading Contract Research Organization providing product development and analytical testing services for the Agrochemical and Pharma/Biopharma markets. John Bucksath, who joined ABC Labs in 1989 and became CEO in 2012, stated ”ABC Laboratories has grown from a small quiet company located in the Midwest to an industry recognized competitor providing regulated services to the pharmaceutical, animal health and agriculture industries. Looking back, the transformation led by Celerity’s investment was critical to position ABC to compete in today’s market. The growth and maturation were a necessary next step in the organization’s journey and has equipped ABC to move to the next level in its continuing evolution. Where we are today would not have been possible without Celerity’s guidance, support and unwavering commitment to all stakeholders.” The ABC exit resulted in approximately a 6.2x cash on cash return for Celerity’s equity investment. News

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.